The Injectable Cytotoxic Drugs Market is witnessing significant growth as global oncology care increasingly relies on injectable formulations to deliver targeted cancer therapies. Valued at US$ 19,625 million in 2024, the market is projected to expand at a CAGR of 6.5% from 2025 to 2032. Rising cancer prevalence, advancements in drug development, and increasing adoption of injectable cytotoxic...
